Recombinant Factor VIIa in Acute Intracerebral Haemorrhage

Completed

Phase 2 Results

Summary of Purpose

This trial is conducted in North America, Europe, Asia and Oceania. The purpose of this study is to evaluate safety and efficacy of Recombinant Factor VIIa in patients with acute intracerebral bleeding.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 June 2012.

1 Aug 2002 24 Jan 2007 1 Jun 2004 1 Jun 2004 1 Sep 2011 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available